Aclaris Therapeutics Inc. Public Market Comparables
Find the most relevant public market comparables for Aclaris Therapeutics Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics (identifying and developing therapies for immuno-inflammatory diseases) and contract research (providing laboratory services). A majority of its revenue comes from the therapeutics segment.
Business Model
Clinical-stage biopharmaceutical company developing and commercializing therapies for immuno-inflammatory diseases. Also provides contract research services.
Target Customers
Patients with immuno-inflammatory diseases; pharmaceutical companies (for contract research).
Specific Focus
Developing novel drug candidates for immuno-inflammatory diseases, with a focus on underserved conditions.
Location
Wayne, Pennsylvania
CEO
Dr. Neal Walker
Industry
Life sciences
Sub Sector
Biopharmaceutical
3yr Revenue Growth
382%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Aclaris Therapeutics Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Aclaris Therapeutics Inc.? Our platform provides detailed analysis of Aclaris Therapeutics Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Aclaris Therapeutics Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Aclaris Therapeutics Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Aclaris Therapeutics Inc. operates in the specialized Biopharmaceutical sub-sector. Understanding how Aclaris Therapeutics Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biopharmaceutical space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Cloudflare, Inc.
Information and communications technology • Software & services
Cloudflare is a global cloud services provider offering a wide range of services to businesses of all sizes, enhancing security, performance, and reliability of their internet properties. They provide content delivery network (CDN) services, cybersecurity, DDoS mitigation, wide area network services, reverse proxies, Domain Name Service, and other services.
Nurix Therapeutics, Inc.
Biotechnology & Drugs • Life sciences
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines to improve treatment options for patients with cancer and inflammatory diseases. Their approach involves modulating cellular protein levels using oral, small molecule therapies.
Bakkt Holdings, Inc.
Financial Technology (Fintech) • Fintech
Bakkt Holdings, Inc. builds technology that enables its clients to deliver new opportunities to their customers through Software as a Service (SaaS) and Application Programming Interface (API) solutions providing crypto trading capabilities and loyalty solutions.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Aclaris Therapeutics Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free